LDC and Roche will jointly advance innovative drug discovery projects

LDC Enters new Industry Partnership for the Discovery of Novel Medicines

25-Jan-2016 - Germany

The Lead Discovery Center GmbH (LDC) and Roche will collaborate to identify and leverage innovative therapeutic opportunities that address diseases of unmet medical need across several disease areas.

Projects will be sourced from the LDC’s academic partners, as well as from Roche’s innovation network. The partners will work together to advance projects from as early as target level up to the identification of a preclinical candidate. Over an initial three year period, LDC will act as a translational incubator for Roche and carry out small molecule projects in close collaboration with the scientific inventors and their academic institutions.

Upon attainment of a predefined milestone, Roche has option rights to an exclusive license. The terms and conditions of collaboration and licensing will be agreed on a project-by-project basis to ensure a fair balance of investments and potential returns between the partners. Any revenue the LDC may receive from a potential future commercialization will be shared with the academic inventors and collaborating institutions. Roche’s contributions will include research funding and possibly in-kind support required for optimal project progress, such as access to compound libraries.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Two colour technique reveals how X-ray lasers damage biomolecules - Step to a fuller understanding of how X-ray flashes modify the structure of proteins

Two colour technique reveals how X-ray lasers damage biomolecules - Step to a fuller understanding of how X-ray flashes modify the structure of proteins

QIAGEN acquires Genoox - "As part of QIAGEN, we can together drive the next wave of precision medicine"

QIAGEN acquires Genoox - "As part of QIAGEN, we can together drive the next wave of precision medicine"

D-Cycloserine Reduces Cocaine-Seeking Behavior in "Addicted" Mice - Antibiotic that appears to control phobias may also be useful in treating addiction

Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Aeras awarded €11.7 million ($16 million) grant from Dutch government

Thermal microscopy of single cells

Thermal microscopy of single cells

Using barcodes to trace cell development - Method will facilitate whole new insights into the development of various tissues as well as cancer

Using barcodes to trace cell development - Method will facilitate whole new insights into the development of various tissues as well as cancer

Merck Millipore offers quick tests for EHEC in food - Easy to use detection for food manufacturers and researchers

One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome - Results Presented at American College of Gastroenterology Annual Meeting Show Majority of Responders Continued to Benefit from GATTEX in Phase 3-Extension Study

Unraveling the genome in 3D-space - Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

Unraveling the genome in 3D-space - Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

MorphoSys Appoints New Head of Preclinical Development - MorphoSys Further Strengthens its Proprietary Development Team